Clinical Trials - Gala Treatment for Chronic Bronchitis in Canada - Chronic Bronchitis

The Gala Airway Treatment system is a device-based, energy delivery system that delivers high frequency short duration energy to the airway epithelium and sub-mucosal tissue layers. The energy is delivered via a proprietary catheter through the bronchoscope.
Treatment will be delivered by a respiratory physician (interventional pulmonologist) in a tertiary teaching hospital.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 12 participants
Intervention Model: Single Group Assignment
Intervention Model Description: Treatment with Gala Airway Treatment System
Masking: None (Open Label)
Primary Purpose: Device Feasibility
Official Title: A Feasibility Study: A Safety Evaluation of the Gala Airway Treatment System on Patients With Chronic Bronchitis in Canada
Actual Study Start Date  January 20, 2017
Estimated Primary Completion Date :  June 30, 2018
Estimated Study Completion Date:  June 30, 2019

Contacts

Contact: Jonathan Waldstreicher, MD jon@galatherapeutics.com
Contact: Deborah Sheffield, MS deb@galatherapeutics.com

Location

Austria
Otto Wagner Spital Recruiting
Wien, Austria, A-1140
Contact: Arschang Valipour, MD    0043 664 4385355    blvr.koordinator@gmail.com   
Principal Investigator: Arschang Valiour, MD
Chile
Clinica Alemana Recruiting
Santiago, Chile
Contact: Carolina Bascuñan    569 934 65819    cbascunan@alemana.cl   
Principal Investigator: Sebastian Fernandez-Bussy, MD
ClinicalTrials.gov Identifier: NCT03107494
* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.